Open AccessXyzal in the treatment of urticaria
Author(s) -
E B Tuzlukova
Publication year - 2009
Publication title -
russian journal of allergy
Language(s) - English
Resource type - Journals
eISSN - 2686-682X
pISSN - 1810-8830
DOI - 10.36691/rja1055
Subject(s) - angioedema , chronic urticaria , medicine , dermatology , hereditary angioedema
The role of various mediators in development of symptoms of urticaria is shown. According to «The National conciliatory document on urticaria and angioedema» principles of diagnostics and treatment are described. It is noted, that unique pathogenetically proved group of the drugs recommended for treatment by patients with urticaria and angioedema, antagonists Н1-receptors are. Data of clinical researches of Xyzal (Levocetirisine) in which are shown it farmacokinetic characteristics, high efficiency and safety are analysed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom